Search for: "Teva Pharmaceuticals"
Results 1221 - 1240
of 1,430
Sort by Relevance
|
Sort by Date
29 May 2009, 4:58 am
Patent 5,583,122, Teva Pharmaceuticals appealed to the US United States Court of Appeals for the Federal Circuit claiming invalidity defenses of obviousness and obviousness-type double patenting. [read post]
28 May 2009, 6:55 pm
Altana and Wyeth were thwarted in their attempt to block Teva Pharmaceuticals from infringing U.S. [read post]
27 May 2009, 9:55 pm
Teva Pharmaceutical Industries Ltd. et al. v. [read post]
27 May 2009, 5:27 am
(Patent Office’s rejection of Glivec’s second variant) (Spicy IP) (Spicy IP) Sweden: Anti-counterfeit barcode technology trialled in Sweden (Managing Intellectual Property) US: ACLU, PUBPAT and others file lawsuit challenging constitutionality of patents on human genes associated with breast and ovarian cancer: Association for Molecular Pathology et al v USPTO et al (Inventive Step) (Holman's Biotech IP Blog) US: Biotech sector highly critical of Commission’s… [read post]
26 May 2009, 9:54 am
., Warrick Pharmaceuticals Corp., TEVA Pharmaceuticals USA, IVAX Corp., IVAX Pharmaceuticals, Barr Laboratories, Aventis Pharmaceuticals, Aventis Behring, ZLB Behring, Sanofi-Synthelabo, Forest Laboratories, Forest Pharmaceuticals, Baxter Healthcare Corp. and Baxter International. [read post]
21 May 2009, 5:18 pm
Teva Pharmaceuticals USA, Inc., P&G sought to prove the date of invention of risedronate - the active ingredient of P&G's osteoporosis drug Actonel ®. [read post]
20 May 2009, 5:18 am
(IP tango) China: China IP forum to bring third patent amendment face-to-face with biotechnology concerns (PatentlyBIOtech) France: Patent and SPC status searches on the INPI website (The SPC Blog) India: Government republishes controversial report on patentability of pharmaceuticals and microorganisms (Managing Intellectual Property) India: The pharmaceutical patent debate: wither drug safety? [read post]
18 May 2009, 7:00 am
Teva Pharms. [read post]
17 May 2009, 9:55 pm
By Andrew Williams -- Last Thursday, the Federal Circuit affirmed the decision of the District Court for the District of New Jersey denying a request by Altana Pharma and Wyeth (collectively "Altana") for a preliminary injunction to prevent Teva Pharmaceuticals ("Teva") from marketing a generic version of the antiulcer drug Protonix ®. [read post]
14 May 2009, 6:35 pm
Teva Pharmaceuticals USA, Inc., No. 08-1039 (Fed. [read post]
14 May 2009, 11:01 am
Teva (Fed. [read post]
13 May 2009, 9:50 pm
After Defendant-Appellant Teva Pharmaceuticals USA, Inc. notified P&G of its intent to market a generic version of... [read post]
13 May 2009, 9:33 am
Teva Pharmaceuticals (Fed. [read post]
11 May 2009, 9:03 am
In October 2005, Wyeth settled patent lawsuit for the same drug with Teva and as per agreement licensed Teva to launch a generic version in July 01, 2010 in return of certain percentage of profits from the generic sale. [read post]
8 May 2009, 8:00 am
(Property intangible) US: Supreme Court rules 9-0 that CAFC has jurisdiction to review case remanded by district court to state court: Carlsbad Technology Inc v HIF Bio, Inc et al (Managing Intellectual Property) (Patently-O) US: Anticipation by a laundry list of prophetic DNA sequences: In re Gleave (Holman's Biotech IP Blog) US: Reverse payment settlements and biotechnology (Holman's Biotech IP Blog) US: Biogen seeks review and correction of patent term adjustment calculation in respect… [read post]
1 May 2009, 9:00 am
(IAM) US: Johnson & Johnson – 5 year exclusivity period would kill incentives to innovate (Patent Docs) US: CHI CEO on patent reform and follow-on biologics legislation (Patent Docs) US: BIO urges Congress on patent reform: First, do no harm (Patent Baristas) US: Pharmaceutical advertising: How to use a domain name to circumvent application of law (Domain Name / Nom De Domaine!) [read post]
24 Apr 2009, 9:25 am
The argument was that the generic makers did not develop the drug's warning label.The lawsuit was filed against Wyeth, which manufactured the drug metoclopramide under the brand name Reglan, and others including Teva Pharmaceuticals USA, Actavis Elizabeth, Barr Pharmaceuticals and Pliva.You can read the opinion here, in PDF format. [read post]
24 Apr 2009, 1:04 am
TEVA PHARMACEUTICALS USA, INC., 1-06-cv-01017 (INSD April 22, 2009, Order) [read post]
23 Apr 2009, 10:00 pm
(Spicy IP) India: Assessing India’s innovation climate (Biotech Blog) Kenya’s anti-counterfeit legislation, India protest (Afro-IP) Mexico: Pharmaceutical trade marks: the Health Law pitfall for applicants (International Law Office) US: BIO IP Counsels’ Committee: Q Todd Dickinson and E Anthony Figg on patent reform (Patent Docs) US: Amgen VP makes case for longer exclusivity period in follow-on biologics legislation (Patent Docs) Products Cepham… [read post]
20 Apr 2009, 2:24 pm
Opinion below (Federal Circuit) Petition for certiorari Brief in opposition (for respondent Amphastar Pharmaceuticals) Brief in opposition (for respondent Teva Pharmaceuticals) Petitioner's reply Brief amicus curiae of Washington Legal Foundation (in support of petitioners) Brief amicus curiae of Ole Nilssen and Geo Foundation Ltd. [read post]
